Erβ has nongenomic action in caveolae

Ken L. Chambliss, Ivan S. Yuhanna, Richard G W Anderson, Michael E. Mendelsohn, Philip W. Shaul

Research output: Contribution to journalArticle

229 Citations (Scopus)

Abstract

ERα and ERβ serve classically as transcription factors, and ERα also mediates nongenomic responses to E2 such as the activation of endothelial nitric oxide synthase (eNOS). In contrast, the nongenomic capacities of endogenous ERβ are poorly understood. We evaluated eNOS activation by E2 in cultured endothelial cells that express endogenous ERβ to determine whether the ERβ isoform has nongenomic action and to reveal the subcellular locale of that function. A subpopulation of ERβ was localized to the endothelial cell plasma membrane, overexpression of ERβ enhanced rapid eNOS stimulation by E2, and the response to endogenous ER activation was inhibited by the ERβ-selective antagonist RR-tetrahydrochrysene (THC). eNOS activation through ERβ was reconstituted and shown to occur independent of ERα in COS-7 cells, and ERβ protein in COS-7 was directed to the plasma membrane. THC also blunted E2 activation of eNOS in isolated endothelial cell plasma membranes. Furthermore, ERβ protein was detected and THC attenuated E2 stimulation of eNOS in isolated endothelial cell caveolae, and functional ERβ-eNOS coupling was recapitulated in caveolae from transfected COS-7 cells. These findings in the ER-eNOS signaling paradigm indicate that endogenous ERβ has nongenomic action in caveolae.

Original languageEnglish (US)
Pages (from-to)938-946
Number of pages9
JournalMolecular Endocrinology
Volume16
Issue number5
DOIs
StatePublished - 2002

Fingerprint

Caveolae
Nitric Oxide Synthase Type III
Cell Membrane
Endothelial Cells
COS Cells
Cultured Cells
Protein Isoforms
Proteins
Transcription Factors

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism

Cite this

Chambliss, K. L., Yuhanna, I. S., Anderson, R. G. W., Mendelsohn, M. E., & Shaul, P. W. (2002). Erβ has nongenomic action in caveolae. Molecular Endocrinology, 16(5), 938-946. https://doi.org/10.1210/me.16.5.938

Erβ has nongenomic action in caveolae. / Chambliss, Ken L.; Yuhanna, Ivan S.; Anderson, Richard G W; Mendelsohn, Michael E.; Shaul, Philip W.

In: Molecular Endocrinology, Vol. 16, No. 5, 2002, p. 938-946.

Research output: Contribution to journalArticle

Chambliss, KL, Yuhanna, IS, Anderson, RGW, Mendelsohn, ME & Shaul, PW 2002, 'Erβ has nongenomic action in caveolae', Molecular Endocrinology, vol. 16, no. 5, pp. 938-946. https://doi.org/10.1210/me.16.5.938
Chambliss KL, Yuhanna IS, Anderson RGW, Mendelsohn ME, Shaul PW. Erβ has nongenomic action in caveolae. Molecular Endocrinology. 2002;16(5):938-946. https://doi.org/10.1210/me.16.5.938
Chambliss, Ken L. ; Yuhanna, Ivan S. ; Anderson, Richard G W ; Mendelsohn, Michael E. ; Shaul, Philip W. / Erβ has nongenomic action in caveolae. In: Molecular Endocrinology. 2002 ; Vol. 16, No. 5. pp. 938-946.
@article{6170835228a84576bad0858de63fcbe7,
title = "Erβ has nongenomic action in caveolae",
abstract = "ERα and ERβ serve classically as transcription factors, and ERα also mediates nongenomic responses to E2 such as the activation of endothelial nitric oxide synthase (eNOS). In contrast, the nongenomic capacities of endogenous ERβ are poorly understood. We evaluated eNOS activation by E2 in cultured endothelial cells that express endogenous ERβ to determine whether the ERβ isoform has nongenomic action and to reveal the subcellular locale of that function. A subpopulation of ERβ was localized to the endothelial cell plasma membrane, overexpression of ERβ enhanced rapid eNOS stimulation by E2, and the response to endogenous ER activation was inhibited by the ERβ-selective antagonist RR-tetrahydrochrysene (THC). eNOS activation through ERβ was reconstituted and shown to occur independent of ERα in COS-7 cells, and ERβ protein in COS-7 was directed to the plasma membrane. THC also blunted E2 activation of eNOS in isolated endothelial cell plasma membranes. Furthermore, ERβ protein was detected and THC attenuated E2 stimulation of eNOS in isolated endothelial cell caveolae, and functional ERβ-eNOS coupling was recapitulated in caveolae from transfected COS-7 cells. These findings in the ER-eNOS signaling paradigm indicate that endogenous ERβ has nongenomic action in caveolae.",
author = "Chambliss, {Ken L.} and Yuhanna, {Ivan S.} and Anderson, {Richard G W} and Mendelsohn, {Michael E.} and Shaul, {Philip W.}",
year = "2002",
doi = "10.1210/me.16.5.938",
language = "English (US)",
volume = "16",
pages = "938--946",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Erβ has nongenomic action in caveolae

AU - Chambliss, Ken L.

AU - Yuhanna, Ivan S.

AU - Anderson, Richard G W

AU - Mendelsohn, Michael E.

AU - Shaul, Philip W.

PY - 2002

Y1 - 2002

N2 - ERα and ERβ serve classically as transcription factors, and ERα also mediates nongenomic responses to E2 such as the activation of endothelial nitric oxide synthase (eNOS). In contrast, the nongenomic capacities of endogenous ERβ are poorly understood. We evaluated eNOS activation by E2 in cultured endothelial cells that express endogenous ERβ to determine whether the ERβ isoform has nongenomic action and to reveal the subcellular locale of that function. A subpopulation of ERβ was localized to the endothelial cell plasma membrane, overexpression of ERβ enhanced rapid eNOS stimulation by E2, and the response to endogenous ER activation was inhibited by the ERβ-selective antagonist RR-tetrahydrochrysene (THC). eNOS activation through ERβ was reconstituted and shown to occur independent of ERα in COS-7 cells, and ERβ protein in COS-7 was directed to the plasma membrane. THC also blunted E2 activation of eNOS in isolated endothelial cell plasma membranes. Furthermore, ERβ protein was detected and THC attenuated E2 stimulation of eNOS in isolated endothelial cell caveolae, and functional ERβ-eNOS coupling was recapitulated in caveolae from transfected COS-7 cells. These findings in the ER-eNOS signaling paradigm indicate that endogenous ERβ has nongenomic action in caveolae.

AB - ERα and ERβ serve classically as transcription factors, and ERα also mediates nongenomic responses to E2 such as the activation of endothelial nitric oxide synthase (eNOS). In contrast, the nongenomic capacities of endogenous ERβ are poorly understood. We evaluated eNOS activation by E2 in cultured endothelial cells that express endogenous ERβ to determine whether the ERβ isoform has nongenomic action and to reveal the subcellular locale of that function. A subpopulation of ERβ was localized to the endothelial cell plasma membrane, overexpression of ERβ enhanced rapid eNOS stimulation by E2, and the response to endogenous ER activation was inhibited by the ERβ-selective antagonist RR-tetrahydrochrysene (THC). eNOS activation through ERβ was reconstituted and shown to occur independent of ERα in COS-7 cells, and ERβ protein in COS-7 was directed to the plasma membrane. THC also blunted E2 activation of eNOS in isolated endothelial cell plasma membranes. Furthermore, ERβ protein was detected and THC attenuated E2 stimulation of eNOS in isolated endothelial cell caveolae, and functional ERβ-eNOS coupling was recapitulated in caveolae from transfected COS-7 cells. These findings in the ER-eNOS signaling paradigm indicate that endogenous ERβ has nongenomic action in caveolae.

UR - http://www.scopus.com/inward/record.url?scp=0036013436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036013436&partnerID=8YFLogxK

U2 - 10.1210/me.16.5.938

DO - 10.1210/me.16.5.938

M3 - Article

C2 - 11981029

AN - SCOPUS:0036013436

VL - 16

SP - 938

EP - 946

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 5

ER -